Roberts SK, et al. - This paper aspired to contemplate the efficacy and safety of Mycophenolate mofetil (MMF) in patients who had failed or were intolerant to corticosteroids with/without azathioprine. Such a treatment was well tolerated as a rescue therapy for autoimmune hepatitis group (AIH). It appeared to be moderately effective in attaining an overall remission rate of 60%. Lower response rates were discovered along with higher infection rates, among those with cirrhosis. Additional exploration of MMF was necessitated.